CIK 0001840439
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- 4 Open-market sale 10% owner sold 34,658 shares at $11.76 ($407,578)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 4,365,342 shares (other)
- 4 Grant or award Chief Financial Officer acquired 3,307 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $8.68 ($86,767)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 34,658 shares at $10.96 ($379,852)
- 4 Open-market buy Director bought 34,658 shares at $10.96 ($379,852)
- 4 Open-market buy President & COO bought 24,000 shares at $13.20 ($316,872)
- 4 Open-market buy CEO bought 24,000 shares at $13.20 ($316,872)
- 4 Open-market buy President & COO bought 204,470 shares at an average $16.15 ($3,301,795)
- 4 Open-market buy CEO bought 204,470 shares at an average $16.15 ($3,301,795)
Page 4 of 5 · 98 filings